BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26999911)

  • 1. False Negative Urine Pregnancy Testing with Complete Molar Pregnancy: An Example of the Hook Effect.
    Anderson Z; Larson E; Khan M; Bell M
    S D Med; 2016 Feb; 69(2):55-7. PubMed ID: 26999911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial hydatidiform mole with false-negative urine human chorionic gonadatropin test in the emergency department.
    Mundangepfupfu T; Waseem M
    J Emerg Med; 2014 Mar; 46(3):348-50. PubMed ID: 24188605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molar pregnancy with false negative urine hCG: the hook effect.
    Pang YP; Rajesh H; Tan LK
    Singapore Med J; 2010 Mar; 51(3):e58-61. PubMed ID: 20428735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine pregnancy test (UPT) hCG negative molar pregnancy: a short report from Masanga/Sierra Leone.
    Gresnigt TM; Sikkema JM
    Trop Doct; 2019 Apr; 49(2):129-132. PubMed ID: 30526377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
    Levavi H; Neri A; Bar J; Regev D; Nordenberg J; Ovadia J
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
    Cole LA; Shahabi S; Butler SA; Mitchell H; Newlands ES; Behrman HR; Verrill HL
    Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative urine pregnancy test in a molar pregnancy: is it possible?
    Nigam A; Kumari A; Gupta N
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25378114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
    Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF
    Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent gestational trophoblastic disease in a case of suspected quiescent gestational trophoblastic disease: a case report.
    Sasaki S; Sasaki Y; Iino K
    J Reprod Med; 2010; 55(7-8):317-20. PubMed ID: 20795345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choriocarcinoma following ovarian hydatidiform mole: a case report.
    Joneborg U; Papadogiannakis N; Lindell G; Marions L
    J Reprod Med; 2011; 56(11-12):511-4. PubMed ID: 22195336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual cause of cardiothyreosis.
    Marchand L; Chabert P; Chaudesaygues E; Grasse M; Bretones S; Graeppi-Dulac J; Aupetit JF
    Gynecol Endocrinol; 2016; 32(2):107-9. PubMed ID: 26559442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperthyroidism and an unexpected molar pregnancy].
    van den Tweel MM; van Dunné FM; Johansson-Vidarsdóttir S
    Ned Tijdschr Geneeskd; 2022 Nov; 166():. PubMed ID: 36633053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Persistent low levels of human chorionic gonadotropin in the serum: investigation and management].
    Faranesh R; Ben-David Y
    Harefuah; 2009 Feb; 148(2):101-3, 139. PubMed ID: 19627038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
    Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI
    Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.